Surgery Roe from 2010 to 2025

SGRY Stock  USD 24.36  0.01  0.04%   
Surgery Partners ROE yearly trend continues to be fairly stable with very little volatility. ROE is likely to outpace its year average in 2025. During the period from 2010 to 2025, Surgery Partners ROE regression line of annual values had r-squared of  0.04 and arithmetic mean of  0.04. View All Fundamentals
 
ROE  
First Reported
2010-12-31
Previous Quarter
(0.09)
Current Value
(0.09)
Quarterly Volatility
0.31121095
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 87.3 M, Interest Expense of 154.1 M or Selling General Administrative of 520.6 M, as well as many indicators such as Price To Sales Ratio of 1.47, Dividend Yield of 0.0014 or PTB Ratio of 1.57. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Roe Growth Pattern

Below is the plot of the Roe of Surgery Partners over the last few years. It is Surgery Partners' ROE historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Roe10 Years Trend
Pretty Stable
   Roe   
       Timeline  

Surgery Roe Regression Statistics

Arithmetic Mean0.04
Geometric Mean0.1
Coefficient Of Variation693.95
Mean Deviation0.18
Median0.06
Standard Deviation0.31
Sample Variance0.1
Range1.4852
R-Value(0.20)
Mean Square Error0.1
R-Squared0.04
Significance0.46
Slope(0.01)
Total Sum of Squares1.45

Surgery Roe History

2025 -0.0892
2024 -0.0939
2023 -0.005988
2022 0.0435
2021 0.0649
2020 0.0112
2019 0.15

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Roe, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
ROE(0.09)(0.09)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.